Loading…

Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: Neuroendocrine evidence for a GABA disturbance in schizophrenia

To substantiate a previously reported disturbance of γ-aminobutyric acid (GABA) in chronic schizophrenia, plasma growth hormone (GH) response to a direct GABA agonist (baclofen, 10 mg) was assessed in 12 unmedicated chronic schizophrenic males and 10 sex- and age-matched healthy controls. Baclofen a...

Full description

Saved in:
Bibliographic Details
Published in:Psychiatry research 1988-10, Vol.26 (1), p.1-9
Main Authors: Monteleone, Palmiero, Maj, Mario, Iovino, Michele, Forziati, Domenico, Veltro, Franco, Steardo, Luca
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To substantiate a previously reported disturbance of γ-aminobutyric acid (GABA) in chronic schizophrenia, plasma growth hormone (GH) response to a direct GABA agonist (baclofen, 10 mg) was assessed in 12 unmedicated chronic schizophrenic males and 10 sex- and age-matched healthy controls. Baclofen and placebo were administered orally, in a double-blind design, and blood samples were collected before and 30, 60, 90, 120, 180, and 240 min after drug or placebo administration. Baclofen induced a clear-cut rise in plasma GH levels over baseline values, but the GH increase observed in the patients was significantly smaller than that in controls. These results support the idea that GABA mechanisms may be impaired in chronic schizophrenia.
ISSN:0165-1781
1872-7123
DOI:10.1016/0165-1781(88)90081-9